HPV Vaccine Acceptability
4
0
0
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
6 treatments under study, led by Integrated Health Service Delivery For Very Young Adolescents
Research Leaders
6 sponsors active, led by Population Services International
Related Conditions
Often studied with 8 related conditions
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
0.0%
0 terminated out of 4 trials
100.0%
+13.4% vs benchmark
25%
1 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (4)
Impact of a School- and Primary Care-based Multicomponent Intervention on HPV Vaccination Acceptability
HPV Vaccine Integrated Service Implementation Research in Cameroon
HPV Vaccine Integrated Service Implementation Research in Ethiopia
A Health Belief Model Based Intervention to Increase Human Papilloma Virus (HPV) Vaccination Among College Men
Research Network
Common Treatments
- Integrated Health Service Delivery For Very Young Adolescents1
- General Practitioners Training Component 21
- Adolescents And Parents Education And Motivation At School Component 11
- Access To Vaccination At School Component 31
- Hpv Vaccine Acceptability1
Active Sponsors
- Population Services International2
- Institut National de la Santé Et de la Recherche Médicale, France1
- Fobang Institutes for Innovations in Science and Technology1
- Addis Ababa University1
- Ministry of Health, Ethiopia1
Top Investigators
GIMAP, EA 3064, Université Jean Monnet, Université de Lyon, Saint-Etienne, France
Département de Médecine Générale - Université Paris, Paris
University of Cincinnati
INSERM, ECEVE UMR 1123, Paris
College of Health Sciences, Addis Ababa University
Related Conditions
- Hpv Vaccinations2
- Adolescent Health Services2
- Hpv Vaccine Attitudes2
- Papillomavirus Vaccines2
- Hpv Vaccines2